Amgen (NASDAQ:AMGN) Price Target Cut to $291.00
Amgen (NASDAQ:AMGN – Free Report) had its price target cut by Morgan Stanley from $300.00 to $291.00 in a research note released on Wednesday morning, Benzinga reports. They currently have an equal weight rating on the medical research company’s stock. Several other research firms also recently weighed in on AMGN. Argus upped their price objective […]
More Stories
Applied Digital (NASDAQ:APLD) Sees Large Volume Increase – What’s Next?
Applied Digital Co. (NASDAQ:APLD – Get Free Report) shares saw strong trading volume on Monday . 9,305,650 shares changed hands...
Kinetik (NASDAQ:KNTK) Hits New 12-Month High – Still a Buy?
Kinetik Holdings Inc. (NASDAQ:KNTK – Get Free Report) shares hit a new 52-week high on Monday . The stock traded...
Maravai LifeSciences (NASDAQ:MRVI) Sets New 12-Month Low – Here’s What Happened
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI – Get Free Report) hit a new 52-week low during trading on Monday . The...
Fidus Investment (NASDAQ:FDUS) Sets New 1-Year High – Here’s What Happened
Fidus Investment Co. (NASDAQ:FDUS – Get Free Report) reached a new 52-week high during trading on Monday . The company...
Celsius (NASDAQ:CELH) Shares Down 0.7% – Time to Sell?
Celsius Holdings, Inc. (NASDAQ:CELH – Get Free Report)’s share price was down 0.7% during mid-day trading on Monday . The...
Inhibrx, Inc. (NASDAQ:INBX) Short Interest Update
Inhibrx, Inc. (NASDAQ:INBX – Get Free Report) was the recipient of a large increase in short interest during the month...